Bahl & Gaynor Inc Boston Scientific Corp Transaction History
Bahl & Gaynor Inc
- $19.6 Billion
- Q1 2025
A detailed history of Bahl & Gaynor Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 4,064 shares of BSX stock, worth $423,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,064
Previous 2,409
68.7%
Holding current value
$423,143
Previous $215,000
90.23%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,832Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$14 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.71 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.8 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.46 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $149B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...